EICHOR
● Active Not Recruiting
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Condition: Inflammatory Bowel Diseases · Colitis, Ulcerative · Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
About this study
This is a Phase 2b randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of three active dose regimens of MORF-057 in adult patients with moderately to severely active Ulcerative Colitis (UC).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (102)
| Arizona Digestive Health - Sun City | Sun City, Arizona, United States | — |
| Gastro Care Institute | Lancaster, California, United States | — |
| TLC Clinical Research Inc. | Los Angeles, California, United States | — |
| Innova Clinical Trials | Coral Gables, Florida, United States | — |
| Eminat, LLC - Miramar | Miramar, Florida, United States | — |
| Robert Wood Johnson University Medical School | New Brunswick, New Jersey, United States | — |
| Great Lakes Gastroenterology | Mentor, Ohio, United States | — |
| The University of Texas Health Science Center at Houston | Houston, Texas, United States | — |
| Blacktown Hospital | Blacktown, Australia | — |
| Concord Repatriation General Hospital | Concord, Australia | — |
| Royal Brisbane and Women's Hospital | Herston, Australia | — |
| Fiona Stanley Hospital | Murdoch, Australia | — |
+ 90 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05611671